Does a mobile app help people with atrial fibrillation take their medication?

Not Applicable

• Conditions: Atrial fibrillation; Circulatory System

• Registration Number: ISRCTN10135302
• Lead Sponsor: Edinburgh Napier University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-08
• Last Update Posted: 14 November 2022
• Study Completion: 2023-03-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients:
1. Adults diagnosed with atrial fibrillation
2. Prescribed oral anticoagulant therapy
3. Able to provide written informed consent in English
4. Participants must have access to a personal device (e.g. mobile or tablet)

Health care professionals:
1. Healthcare professionals working at study recruitment sites who have had involvement in recruitment of study participants
2. Healthcare professionals working at study recruitment sites who have had involvement in taking blood samples for study participants

Exclusion Criteria

Patients:
1. Patients with unstable atrial fibrillation or newly initiated on warfarin
2. Patients with atrial fibrillation who are not prescribed oral anticoagulant therapy
3. Patients who are unable to provide written informed consent in English
4. Patients who do not have access to a personal device (e.g. mobile or tablet)

Health care professionals:
1. Healthcare professionals working at study recruitment sites who have not had involvement in recruitment of study participants or taken blood samples for study participants

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Measured at week 1, 12 and 24:<br> 1. Medication adherence measured using blood assay measures (Anti-Xa or International Normalised Ratio)<br> 2. Medication adherence measured using the Medication Adherence Rating Scale<br> 3. Beliefs about Medications Questionnaire scores<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Quality of life assessed via (SF-12 questionnaire) at baseline, 12 weeks and 24 weeks<br> 2. AF morbidity (e.g. AF related hospitalization) assessed via a self-reported healthcare questionnaire at 12 weeks and 24 weeks<br> 3. Patient barriers and facilitators to using a mobile health app to manage their AF assessed via semi-structured interviews after 12 weeks<br> 4. Healthcare professional experiences of implementing a mobile health app to increase medication adherence between 12 and 24 weeks<br>